Physician

Timothy Glenn Gentner, M.D.

According to 2025 Medicare claims, Timothy Gentner, M.D. (NPI: 1073576609) practices family practice in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON MEDICAL GROUP PROFESSIONAL CORPORATION (NPI: 1780694620; TIN: 880133501) and primary practice location at 89706-0674. Gentner is affiliated with the Silver State ACO LLC (ACO ID: A2251), participating under the MSSP model.

Gentner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 539 traditional Medicare patients, billed 3,089 HCPCS/CPT codes, and received $171,218 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,807 prescription claims across 639 beneficiaries totaling $429,908 in drug costs, led by Eliquis (Apixaban). DME data shows 27 claims. Open Payments data shows 23 records totaling $395. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $294,474 to $429,908. In contrast, DME billing represents a smaller volume and declined steadily, from $16,489 to $3,697.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	551	1,578	$107,239
2016	552	2,052	$144,110
2017	653	2,295	$163,325
2018	688	2,220	$150,063
2019	659	2,235	$155,451
2020	639	3,074	$170,251
2021	674	3,343	$189,470
2022	763	3,130	$196,471
2023	554	2,358	$157,201
2024	539	3,089	$171,218

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	464	5,205	$294,474
2016	486	5,253	$286,426
2017	572	6,206	$334,780
2018	578	5,798	$370,541
2019	615	6,435	$391,269
2020	619	6,862	$411,862
2021	625	6,957	$541,515
2022	617	6,405	$551,599
2023	618	6,360	$541,630
2024	639	6,807	$429,908

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	105	352	$14,794
2016	105	340	$10,760
2017	68	261	$5,707
2018	45	187	$3,939
2019	40	204	$4,085
2020	38	170	$5,196
2021	31	152	$8,476
2022	12	137	$8,939
2023	12	53	$4,551
2024	N/R	27	$973

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	336	336	$125
90662	Influenza vaccine split virus, preservative free	120	122	$79
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	404	474	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	298	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	417	628	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	45	2,940	$56,405
Jardiance	Empagliflozin	19	1,710	$32,421
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	1,380	$29,224
Breo Ellipta	Fluticasone/Vilanterol	57	1,710	$21,995
Januvia	Sitagliptin Phosphate	11	930	$20,334

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$771
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	15	$202

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$395	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy Glenn Gentner, M.D.?

Tedicare shows public-source Medicare data for Timothy Glenn Gentner, M.D. (NPI 1073576609), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Glenn Gentner, M.D. have ACO affiliation data?

Timothy Glenn Gentner, M.D. is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251).

What billing organization is linked to Timothy Glenn Gentner, M.D.?

Timothy Glenn Gentner, M.D. is linked to CARSON MEDICAL GROUP PROFESSIONAL CORPORATION (billing NPI 1780694620) in the available physician profile data.

Does Timothy Glenn Gentner, M.D. have Open Payments data?

Timothy Glenn Gentner, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.